Nicholas Fleming

Molecular cancer research PI based at the University of Otago, NZ, identifying novel cancer driving mechanisms and therapeutic opportunities. Views are my own.

[Nicholas Fleming @nifleming]

A new review from us: Are single nucleotide polymorphisms underutilized for guiding treatment of inflammatory bowel disease? https://t.co/Q8CzJUs2Ep

[Nicholas Fleming @nifleming]

Great to see! - "pre-surgery immunotherapy to become the global standard approach to combating melanoma"
https://t.co/wM3cyXjdlu

[Ethan Scott's Lab @LabEthan]

JOIN US! We're seeking a new PhD student in beautiful Melbourne🇦🇺 @UniMelb. Join our diverse, supportive team of physicists, neuroscientists, and mathematicians as study how #zebrafish brains perceive the world. Deadline: May 9th. Details👇. Please RT

[Nicholas Fleming @nifleming]

@ppgardne In fact you probably owe blue cod a vote to be fair.

[Nicholas Fleming @nifleming]

@ppgardne Not on the list.

[Kylie Quinn @DrQuinn4realz]

Just bumping this up again into your scrolls 😉 We are keen to recruit an immunology-focused RA to join our team looking at ageing, vaccines and CAR T cell therapy- apps due this Sunday!

[Nicholas Fleming @nifleming]

Encouraging phase II results from new combination strategies for immune checkpoint inhibitors in MSS/pMMR bowel cancers.

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer https://t.co/ldLbod8MFM @KoheiShitara

[Helen Clark @HelenClarkNZ]

Eyebrows raised as NZ drops support for proposal to restrict #bottomtrawling in Sth Pacific, notwithstanding that it originally proposed it. All that has changed is NZ Govt, not the proposal’s merits; protection for threatened marine ecosystems is vital: https://t.co/XdX9tYEfWm

[Nicholas Fleming @nifleming]

Exciting and compelling Phase I data from a new albumin-hitchhiking cancer vaccine for fighting colorectal and pancreatic cancers...

[Dr. Shubham Pant @DrShubhamPant]

🚨🚨On behalf of my Co-investigators: 🤩🤩excited to finally see in 📖📖 print

Phase 1 AMPLIFY-201 trial @NatureMedicine

https://t.co/Medb1PfpTt

👉Eli-002 vaccine for G12D and G12R mutant KRAS

[Nicholas Fleming @nifleming]

@DrDaleGarsed @nhmrc @BowtellLab @PeterMacCC @BCCancer Congrats Dale! Great to see.

[Rebecca Campbell @RECampbell_inNZ]

Please spread the word. Exciting opportunity to come work in the Campbell Lab @CneOtago https://t.co/VwzZtDHKGY

[Nicholas Fleming @nifleming]

@KiwiFarah Slightly apocalyptic.

[Nicholas Fleming @nifleming]

Another great talk chalked up today by Jildou van der Werf from our lab. Thanks @GeneticsOtago Symposium 2023.

[Nicholas Fleming @nifleming]

@ProlactinGuy @IFPA_Official @drjojames Seen these two yet?

[Nicholas Fleming @nifleming]

Exciting lineup for Falling Walls Lab, NZ - including Jildou van der Werf from our team. Best of luck to all!

[Royal Society Te Apārangi @royalsocietynz]

Falling Walls Lab Aotearoa New Zealand is tomorrow!
Watch 22 participants present their innovative research, scientific idea, or evidence-based initiative in three minutes.
Sign up for the live stream at https://t.co/SnBPdYWkzd

[justin M. O'Sullivan @DrJOSull]

I have two opportunities for PhD students to investigate the Genetics of complex disease through Multimodal Approaches and Machine Learning.

You will work on unravelling the complexities of co-occurring diseases and contributing to the development of personalized treatments.

[Nicholas Fleming @nifleming]

Nice morning, Otago Peninsula, NZ.

[Nicholas Fleming @nifleming]

Good at flow cytometry? Our university (University of Otago, NZ) is recruiting a permanent part-time flow cytometry specialist to help run our flow facility: https://t.co/T9XHi1q6Yi

[James Murphy @pseudokinase]

Come work with us @WEHI_research We are working to understand how cell death goes awry in Crohn’s and colitis. If you are a western blot champion, we want you. Applications close on August 25

https://t.co/TBp08nWpeD

[Robert Weinkove @robweinkove]

We have an exciting CAR T cell Clinical Fellow position in Wellington, New Zealand, from in February 2024. Come and work on our clinical trial (& manufacturing) programme of a novel third generation CAR T cell product! https://t.co/fgYIw6paou